These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 16311091

  • 1. Effects of thorough mastication on postprandial plasma glucose concentrations in nonobese Japanese subjects.
    Suzuki H, Fukushima M, Okamoto S, Takahashi O, Shimbo T, Kurose T, Yamada Y, Inagaki N, Seino Y, Fukui T.
    Metabolism; 2005 Dec; 54(12):1593-9. PubMed ID: 16311091
    [Abstract] [Full Text] [Related]

  • 2. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E, Menschikowski M, Koehler C, Leonhardt W, Hanefeld M.
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [Abstract] [Full Text] [Related]

  • 3. Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance.
    Rosenstock J, Foley JE, Rendell M, Landin-Olsson M, Holst JJ, Deacon CF, Rochotte E, Baron MA.
    Diabetes Care; 2008 Jan; 31(1):30-5. PubMed ID: 17947341
    [Abstract] [Full Text] [Related]

  • 4. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I, Weiss R, Yegorchikov Y, Bitton G, Nagar R, Pesach B.
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [Abstract] [Full Text] [Related]

  • 5. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.
    Abdul-Ghani MA, Williams K, DeFronzo R, Stern M.
    Diabetes Care; 2006 Jul; 29(7):1613-8. PubMed ID: 16801587
    [Abstract] [Full Text] [Related]

  • 6. [Characteristics of dysfunction of islet beta-cell in newly diagnosed type 2 diabetic patients].
    Li YB, Zhu DL, Tian HM, Shi LX, Luo ZJ, Yan L, Zeng LY, Zhou ZG, Yang LY, Liu J, Li M, Weng JP.
    Zhonghua Yi Xue Za Zhi; 2006 Sep 26; 86(36):2537-41. PubMed ID: 17198561
    [Abstract] [Full Text] [Related]

  • 7. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
    Hücking K, Kostic Z, Pox C, Ritzel R, Holst JJ, Schmiegel W, Nauck MA.
    Diabet Med; 2005 Apr 26; 22(4):470-6. PubMed ID: 15787675
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N, Hara K, Yatsuka C, Nakano T, Matsumoto S, Suetsugu M, Nakamachi T, Takebayashi K, Inukai T, Haruki K, Aso Y.
    Metabolism; 2009 Oct 26; 58(10):1470-6. PubMed ID: 19592051
    [Abstract] [Full Text] [Related]

  • 12. Effects of breakfast meal composition on second meal metabolic responses in adults with Type 2 diabetes mellitus.
    Clark CA, Gardiner J, McBurney MI, Anderson S, Weatherspoon LJ, Henry DN, Hord NG.
    Eur J Clin Nutr; 2006 Sep 26; 60(9):1122-9. PubMed ID: 16670695
    [Abstract] [Full Text] [Related]

  • 13. Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance.
    Garcia AL, Otto B, Reich SC, Weickert MO, Steiniger J, Machowetz A, Rudovich NN, Möhlig M, Katz N, Speth M, Meuser F, Doerfer J, Zunft HJ, Pfeiffer AH, Koebnick C.
    Eur J Clin Nutr; 2007 Mar 26; 61(3):334-41. PubMed ID: 16988651
    [Abstract] [Full Text] [Related]

  • 14. No acute effect of nateglinide on postprandial lipid and lipoprotein responses in subjects at risk for type 2 diabetes.
    Johanson EH, Jansson PA, Gustafson B, Sandqvist M, Taskinen MR, Smith U, Axelsen M.
    Diabetes Metab Res Rev; 2005 Mar 26; 21(4):376-81. PubMed ID: 15724236
    [Abstract] [Full Text] [Related]

  • 15. Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects.
    Carey PE, Halliday J, Snaar JE, Morris PG, Taylor R.
    Am J Physiol Endocrinol Metab; 2003 Apr 26; 284(4):E688-94. PubMed ID: 12453829
    [Abstract] [Full Text] [Related]

  • 16. Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance.
    Muscelli E, Mari A, Natali A, Astiarraga BD, Camastra S, Frascerra S, Holst JJ, Ferrannini E.
    Am J Physiol Endocrinol Metab; 2006 Dec 26; 291(6):E1144-50. PubMed ID: 16478775
    [Abstract] [Full Text] [Related]

  • 17. The acute impact of ingestion of breads of varying composition on blood glucose, insulin and incretins following first and second meals.
    Najjar AM, Parsons PM, Duncan AM, Robinson LE, Yada RY, Graham TE.
    Br J Nutr; 2009 Feb 26; 101(3):391-8. PubMed ID: 18570696
    [Abstract] [Full Text] [Related]

  • 18. Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects.
    Arakawa M, Ebato C, Mita T, Fujitani Y, Shimizu T, Watada H, Kawamori R, Hirose T.
    Metabolism; 2008 Sep 26; 57(9):1299-306. PubMed ID: 18702958
    [Abstract] [Full Text] [Related]

  • 19. [The relationship between insulin resistance and postprandial abnormal serum triglyceride metabolism in essential hypertension].
    Lin J, Peng F, Zeng K, Wu K, Kang Q.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 25; 82(22):1521-4. PubMed ID: 12609058
    [Abstract] [Full Text] [Related]

  • 20. Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes.
    Linnebjerg H, Kothare PA, Skrivanek Z, de la Peña A, Atkins M, Ernest CS, Trautmann ME.
    Diabet Med; 2006 Mar 25; 23(3):240-5. PubMed ID: 16492205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.